Methods and compositions relating to psychedelics and serotonin receptor modulators
AssigneesTerran Biosciences Inc., University of Maryland, Baltimore
InventorsSam CLARK, Scott THOMPSON
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions relating to psychedelics and serotonin receptor modulators. Further provided herein are methods of treating a disease or disorder (e.g., depression or diseases or disorders related to depression) comprising administering psychedelics and serotonin receptor modulators.
Claims95
A composition comprising:
- a) a psychedelic;
- b) a serotonin receptor modulator;
- and
- c) an excipient,
- wherein the serotonin receptor modulator is released at most about 3 hours prior to the release of the psychedelic.
A method of treating a disease or disorder in a subject in need thereof, the method comprising administering to the subject a composition comprising:
- a) a psychedelic;
- b) a serotonin receptor modulator;
- and
- c) an excipient,
- wherein the serotonin receptor modulator is released at most about 3 hours prior to the release of the psychedelic.
A method of treating a disease or disorder in a subject in need thereof, the method comprising administering to the subject a psychedelic and a serotonin receptor modulator, wherein the serotonin receptor is administered prior to the administration of the psychedelic, and wherein the serotonin receptor modulator is administered at most about 3 hours prior to the administration of the psychedelic.
A method of treating a disease or disorder in a subject in need thereof, the method comprising (i) administering to the subject a serotonin receptor modulator to pretreat the subject, and (ii) administering to the subject a psychedelic, and wherein the serotonin receptor modulator is administered at most about 3 hours prior to the administration of the psychedelic.
A method of reducing the adverse effects of a psychedelic in the treatment of a disease or disorder in a subject in need thereof, the method comprising (i) administering to the subject a serotonin receptor modulator to pretreat the subject, and (ii) administering to the subject a psychedelic, and wherein the serotonin receptor modulator is administered at most about 3 hours prior to the administration of the psychedelic.
Dependencies are inferred from the claim text.